Dr. Christine Moissl-Eichinger Christine Moissl-Eichinger is a microbiologist and since September 2014 BioTechMed professor for “interactive microbiome research” at the Medical University Graz. She is particularly interested in the interaction of the human microbiome with our close, biotic and abiotic environment and the impact of the human-associated microbes on health and well-being. She has a long expertise in the microbial analyses of indoor environments, such as intensive care units or space-craft associated clean rooms. Her interest in indoor microbiology is not restricted to terrestrial environments: In a current project, she and her team will analyse the microbial community of the International Space Station ISS. Her particular focus is on special members of the (human) microbiome- including hard-to-cultivate microorganisms (e.g. extremely oxygen-sensitive microbes) but also the so-called Archaea, a wide-spread but hardly recognized and distinct group of microorganisms.
Dr. Dagmar Iber Dagmar Iber studied mathematics and biochemistry in Regensburg, Cambridge, and Oxford. She holds Master degrees and PhDs in both disciplines. After three years as a Junior Research Fellow in St John’s College, Oxford, Dagmar became a lecturer in Applied Mathematics at Imperial College London. Dagmar has joined ETH Zurich in 2008 after returning from an investment bank where she worked as an oil option trader for one year.
Dagmar Iber’s group develops data-based, predictive models to understand the spatio-temporal dynamics of signaling networks. Close collaborations with experimental laboratories permit a cycle of model testing and improving. Her recent work focuses on mouse organogenesis (limb and brain development, lung and kidney branching morphogenesis) and simpler patterning systems to address more fundamental questions regarding the control of organ growth and the robustness of signalling mechanisms to evolutionary change. Dr. Dagmar Chase Dagmar Chase earned a master's degree in Computer Science (secondary focus on Theoretical Medicine) from the Technical University in Munich and holds a doctorate in Human Biology from the Medical Faculty in Ulm, Germany. Dagmar Chase co-founded, together with Prof. Dr. Albrecht Neiss, the company GMI, a full service CRO for clinical trials phase II - IV, in 1983. Besides developing GMI into one of the largest CROs in Germany, Dagmar Chase concentrated on Quality Management as well as the development of training programs for the pharmaceutical industry. After selling GMI to Kendle in 1997, she worked on global development programs, being a vice-president at Kendle. In 2004, Dagmar started up Clinrex, a consultancy firm for clinical research. Besides providing training, she offers services covering all aspects of GCP and Quality Management in clinical trials, e.g., GCP gap analyses, SOP development, audits and inspection readiness programs. Dagmar Chase is a co-founder of the German CRO association BVMA, which was established in 1991. She was the president of the BVMA from 2001 until the end of 2017. In addition, Dr. Chase is a co-founder of EUCROF, the European CRO Federation, and held the position of vice-president for 10 years until the end of 2016. She chairs the EUCROF Clinical Trials Legislation Working Group and represents EUCROF at numerous EMA stakeholder meetings.